January 2020 — Laboratory Genetics and Genomics - Insights
A 19 year old female with a complex phenotype suggestive of a mitochondrial disorder had mitochondrial DNA sequencing performed three times at an outside
Pathways Case Studies: January 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for January include the following sub-specialties: bone and soft tissue, cellular...
MCL @Work: Robin Huiras-Carlson - Insights
Robin Huiras-Carlson's connection with Mayo Clinic traces back to her early years, marked by a diagnosis of a rare genetic condition at the age of 10. Today, as a senior marketing specialist with Mayo Clinic Laboratories, she draws...
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Focused Pharmacogenomics Panel [Test in Focus] - Insights
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for...
New Tests Launched in April - Insights
In April 2020, Mayo Clinic Laboratories announced four new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Behind the scenes in neural antibody testing - Insights
In this month’s “Hot Topic,” John Mills, Ph.D., explains the central role of tissue immunofluorescence in the identification of neural antibodies and discusses the benefits of an integrated laboratory approach to the development and...
Talking omicron with Matthew Binnicker, Ph.D. - Insights
With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.
July 2023 - Breast Pathology Case 1 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
July 2023 - Breast Pathology Case 2 - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Breast Pathology.
Eight Ways to Enhance Your Teaching and Learning - Insights
Jeremy Zacher, Education Specialist in the Department of Laboratory Medicine and Pathology, highlights eight ways to enhance your teaching and learning.
April 2023 - Cellular Therapy and Transfusion Medicine - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case’s sub-specialties are Cellular Therapy and Transfusion Medicine.
What's New in Quality and Regulatory Expectations for Laboratories? [2022] - Insights
PACE / State of FLThis “Continual Improvement” webinar will provide an overview of new or changed regulations for 2022, and other regulatory issues that have the potential to affect clinical laboratories. The latter half of the year has...
Assessment for Zika Virus Infection in Pregnant Women [Algorithm] - Insights
The algorithm can be viewed here.
COVID-19 weekly news: March 7-11 2022 - Insights
Topic's Include: Losing sleep during the pandemic? It may be affecting your weight, heart, and overall health, and how to deal with anxiety, stress when the world feels overwhelming.
Tales from the Dark Side: Collecting Blood for Commercial Labs - Insights
Skip to Content MayoACCESS MayoLINK...
Complex testing offers answers and guidance about a lifelong illness - Insights
For patients with chronic lymphocytic leukemia (CLL) — the most common leukemia in adults — advanced testing can not only provide valuable information about their disease state, but peace of mind in the face of a progressive, incurable...
A novel testing approach for newly identified VEXAS syndrome - Insights
VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...
Syphilis Testing Updates: Elitza Theel, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, to...
What to Know About Leprosy: Nancy Wengenack, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories...
Bobbi Pritt, M.D., on Asian Longhorned Tick in U.S - Insights
According to the Centers for Disease Control and Prevention (CDC), the Asian longhorned tick has spread across nine states since it first appeared in the U.S. Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory and...
MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights
Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.
Phage immunoprecipitation sequencing identifies previously unknown disease biomarkers - Insights
In Mayo Clinic’s Advanced Diagnostics Laboratory, there are dozens of projects underway at once to develop new technologies, discover novel findings, validate new tests, and support physicians in providing advanced patient care. For...
Testing for a surprising antigen enables insight into a chronic kidney illness - Insights
Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about...
Understanding a Broken Heart: Genetic Testing After Sudden Cardiac Death - Insights
PACE/State of FLPresentation Recording Coming Soon Sudden cardiac death (SCD) is a devastating event that occurs unexpectedly, often without any prior symptoms. This webinar will discuss how postmortem genetic testing may be used in...
Mayo Clinic Infectious Disease Study Noted in Clinical Microbiology Newsletter - Insights
An article recently published in the Clinical Microbiology Newsletter made mention of a Mayo Clinic study. The article discussed a topic that has become increasingly popular—self-collected specimens.
Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights
By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...
Mary Jo Williamson discusses organizational alignment on Becker's Healthcare Podcast - Insights
Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, joins “Becker’s Healthcare Podcast” to discuss organizational alignment during times of change. She shares her expertise on creating transparency, fostering open...
Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice - Insights
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with podcast host Bobbi...
In this month’s “Virtual Lecture,” James Hernandez, M.D., expresses the importance of safety and why it is integral in processing and phlebotomy.
Dr. Morice joins Becker’s Healthcare to discuss how a platform approach to diagnostics and strategic collaborations enhances outcomes.
The Prostate Health Index (PHI) in Prostate Cancer Risk Assessment - Insights
In this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to...
Accurately characterize marijuana use through urine THC testing - Insights
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and...
Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting...
Cardiovascular Events in Patients With or Without Coronary Artery Disease
A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as...
RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. - Insights
Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.
New Panels Help Find Cause of Rapidly Progressive Dementia: Gregg Day, M.D. - Insights
Rapidly progressive dementia (RPD) is an umbrella term covering many devasting conditions, including Creutzfeldt-Jakob disease (CJD). Gregory (Gregg) Day, M.D., explains how Mayo Clinic Laboratories' unique RPD evaluation and new CJD test...
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, to discuss how...
Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D., explain how Mayo Clinic Laboratories' updated neuromuscular gene panel informs diagnosis and treatment. The phenotype-based panel covers the complete list of neuromuscular genes and...
MCL Urine PreservativesCollection and Transportation for 24Hour Urine Specimens MC123587
MCL Urine PreservativesCollection Transportation 24Hour Urine Specimens Urine Preservatives Collection Transportation 24 Hour Urine Specimens Department Laboratory Medicine Pathology Clinic
MCL Urine Preservative Chart MC123587
MCL Urine Preservative Chart Urine Preservatives Collection Transportation 24 Hour Urine Specimens Department Laboratory Medicine Pathology Clinic
international-shipping-guide.pdf
IN TERN ATIO N AL SH IPPIN G G U ID ESEND TESTING TO MAYO CLINIC FROM AROUND THE WORLD 2 | INTERNATIONAL SHIPPING GUIDE UNITED STATES SHIPPING GUIDE | 2 TABLE OF CONTENTS SHIP TO US FROM AROUND THE WORLD 3 Prior to...
united-states-shipping-guide.pdf
U N ITED STATES SH IPPIN G G U ID E TRANSPORTING SPECIMENS WITHIN THE UNITED STATES 2 | UNITED STATES SHIPPING GUIDE UNITED STATES SHIPPING GUIDE | 2 TABLE OF CONTENTS STEP ONE | DANGEROUS GOODS 3 Obtain dangerous...
international-shipping-guide-portuguese.pdf
IN STRU Ç Õ ES PARA EN VIO IN TERN AC IO N ALENVIO DE EXAMES PARA A MAYO CLINIC DE QUALQUER PARTE DO MUNDO 2 | INSTRUÇÕES PARA ENVIO INTERNACIONAL ÍNDICE ENVIO DE EXAMES DE QUALQUER PARTE DO MUNDO 3 Antes de enviar o seu...
CPT Codes and LOINC Update: May 2020 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of May.
lupus_anticoagulant_profile_testing_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2023 Lupus Anticoagulant Profile Testing Algorithm *Weak lupus anticoagulant may not inhibit DRVVT Mix ** Additional assays may be performed if...
Mayo Clinic Laboratory and pathology research roundup: October 11 - Insights
This week's research roundup features: Transcriptomic analysis of cirrhosis-like hepatocellular carcinoma reveals distinct molecular characteristics and pathologic staging implications
Audrey Schuetz, M.D., Comments on First-Ever Case of Human Eye Worms - Insights
A recent article in HealthDay News reported on a case of an avid 26-year-old outdoorswoman from Oregon who became the first human ever infected by a type of eye worm previously seen only in cattle. Audrey Schuetz, M.D., Senior Associate...
Mayo Clinic Laboratory and pathology research roundup: December 13 - Insights
This week's research roundup features: In vitro activity of a hypochlorous acid-generating electrochemical bandage against yeast biofilms
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. AATHR / Thrombophilia Profile, Plasma and Whole Blood Testing begins with: ■ Prothrombin Time (PT), Plasma ■ Activated Partial Thromboplastin Time (APTT),...